Chronic Obstructive Pulmonary Disease Market Report: A Thorough Understanding of the Disease,

LAS VEGAS - Nov. 23, 2021 - PRLog -- DelveInsight's "Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Chronic Obstructive Pulmonary Disease , historical and forecasted epidemiology as well as the Chronic Obstructive Pulmonary Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Chronic Obstructive Pulmonary Disease is a common, treatable, and preventable disease characterized by airflow limitation and persisting respiratory symptoms due to alveolar and/or airway abnormalities usually caused by significant exposure to noxious gases or particles. The common respiratory symptoms include cough, dyspnea, and/or sputum production. The main risk factor includes tobacco smoking, with other factors like environmental exposures such as biomass fuel exposure and air pollution significantly contributing to COPD.

Some of Chronic Obstructive Pulmonary Disease Companies:

• GlaxoSmithKline
• Theravance
• Innoviva
• Sanofi
• Regeneron Pharmaceuticals
• And many others

Chronic Obstructive Pulmonary Disease Therapies Covered:

• Anoro Ellipta
• Incruse Ellipta
• Encruse Ellipta
• Itepekimab (SAR440340/REGN3500/Anti-IL-33 mAb)
• Dupixent (Dupilumab)
• And Many Others

Request for Chronic Obstructive Pulmonary Disease Market Report:
https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market

Media Contact:
Company Name: DelveInsight Business Research LLP
Contact Person: Sheeran S.
Email: info@delveinsight.com
Phone: +19193216187
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/